- Home
- PBYI vs NPV Comparison
PBYI vs NPV Comparison
Compare PBYI & NPV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PBYI
- NPV
- Stock Information
- Founded
- PBYI 2010
- NPV 1993
- Country
- PBYI United States
- NPV United States
- Employees
- PBYI N/A
- NPV N/A
- Industry
- PBYI Biotechnology: Pharmaceutical Preparations
- NPV Investment Managers
- Sector
- PBYI Health Care
- NPV Finance
- Exchange
- PBYI Nasdaq
- NPV Nasdaq
- Market Cap
- PBYI 171.7M
- NPV 199.1M
- IPO Year
- PBYI N/A
- NPV N/A
- Fundamental
- Price
- PBYI $3.28
- NPV $10.91
- Analyst Decision
- PBYI Strong Buy
- NPV
- Analyst Count
- PBYI 1
- NPV 0
- Target Price
- PBYI $7.00
- NPV N/A
- AVG Volume (30 Days)
- PBYI 351.2K
- NPV 38.9K
- Earning Date
- PBYI 08-07-2025
- NPV 01-01-0001
- Dividend Yield
- PBYI N/A
- NPV 3.90%
- EPS Growth
- PBYI 143.51
- NPV N/A
- EPS
- PBYI 0.77
- NPV N/A
- Revenue
- PBYI $232,709,000.00
- NPV N/A
- Revenue This Year
- PBYI N/A
- NPV N/A
- Revenue Next Year
- PBYI N/A
- NPV N/A
- P/E Ratio
- PBYI $4.25
- NPV N/A
- Revenue Growth
- PBYI 2.68
- NPV N/A
- 52 Week Low
- PBYI $2.23
- NPV $8.92
- 52 Week High
- PBYI $4.13
- NPV $11.55
- Technical
- Relative Strength Index (RSI)
- PBYI 40.98
- NPV 25.10
- Support Level
- PBYI $3.34
- NPV $11.28
- Resistance Level
- PBYI $3.55
- NPV $11.35
- Average True Range (ATR)
- PBYI 0.13
- NPV 0.06
- MACD
- PBYI -0.02
- NPV -0.04
- Stochastic Oscillator
- PBYI 11.11
- NPV 8.33
About PBYI Puma Biotechnology Inc
Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes inventive products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also it develops alisertib. Alisertib is a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis resulting into apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.
About NPV Nuveen Virginia Quality Municipal Income Fund
Nuveen Virginia Quality Municipal Income Fund is a diversified closed-end management investment company. The fund seeks to provide current income exempt from both regular federal and designated state income taxes. The fund invests in a portfolio of municipal obligations issued by state and local government authorities.